Literature DB >> 13130402

Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns.

Aude Antignac1, Magaly Ducos-Galand, Annie Guiyoule, René Pirès, Jean-Michel Alonso, Muhamed-Kheir Taha.   

Abstract

Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for approximately 30% of isolates during this period, warranting continued surveillance of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130402     DOI: 10.1086/377739

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

2.  Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.

Authors:  Douglas J Biedenbach; Mariana Castanheira; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

3.  Neisseria meningitidis C:2b:P1.2,5 with decreased susceptibility to penicillin isolated from a patient with meningitis and purpura fulminans.

Authors:  P Fangio; L Desbouchages; J C Lachérade; B De Jonghe; J P Terville; M Leneveu; H Outin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 4.  Mixed bacterial meningitis due to Streptococcus pneumoniae and Neisseria meningitidis in an 18-month-old child.

Authors:  H Marchandin; V Ventura; J-M Alonso; P Van de Perre
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

6.  Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams.

Authors:  Nouria Belkacem; Eva Hong; Ana Antunes; Aude Terrade; Ala-Eddine Deghmane; Muhamed-Kheir Taha
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

7.  Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.

Authors:  Muhamed-Kheir Taha; Maria Leticia Zarantonelli; Arianna Neri; Rocío Enriquez; Julio A Vázquez; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Management of a rifampicin-resistant meningococcal infection in a teenager.

Authors:  D Delaune; D Andriamanantena; A Mérens; E Viant; O Aoun; F Ceppa; M-K Taha; C Rapp
Journal:  Infection       Date:  2013-02-14       Impact factor: 3.553

9.  Changing epidemiology of bacterial meningitis.

Authors:  Mark Alain Dery; Rodrigo Hasbun
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725

10.  Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.

Authors:  Muhamed-Kheir Taha; Julio A Vázquez; Eva Hong; Desiree E Bennett; Sophie Bertrand; Suzana Bukovski; Mary T Cafferkey; Françoise Carion; Jens Jørgen Christensen; Mathew Diggle; Giles Edwards; Rocío Enríquez; Cecilia Fazio; Matthias Frosch; Sigrid Heuberger; Steen Hoffmann; Keith A Jolley; Marcin Kadlubowski; Amel Kechrid; Konstantinos Kesanopoulos; Paula Kriz; Lotte Lambertsen; Ileanna Levenet; Martin Musilek; Metka Paragi; Aouatef Saguer; Anna Skoczynska; Paola Stefanelli; Sara Thulin; Georgina Tzanakaki; Magnus Unemo; Ulrich Vogel; Maria Leticia Zarantonelli
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.